IGM BIOSCIENCES INC.

IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement

22 июн 2023 07:58:50 Источник Nasdaq GlobeNewswire

IGM Announces Proposed Public Offering and Concurrent Private Placement

21 июн 2023 17:17:00 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development

02 июн 2023 17:30:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the Jefferies Healthcare Conference

01 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis

31 май 2023 07:00:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update

30 май 2023 07:00:00 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update

12 май 2023 09:05:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at Two Upcoming Investor Conferences

02 май 2023 07:00:01 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days

19 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces Six Presentations at the American Society for Cancer Research Annual Meeting 2023

13 апр 2023 16:05:00 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

30 мар 2023 16:05:01 Источник Nasdaq GlobeNewswire

IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023

27 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference

02 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire

IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors

17 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development

09 янв 2023 07:37:34 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 янв 2023 07:00:01 Источник Nasdaq GlobeNewswire

IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting

11 дек 2022 10:00:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at the Bank of America Biotech SMID Cap Conference

01 дек 2022 07:00:00 Источник Nasdaq GlobeNewswire

IGM Biosciences to Present at Three Upcoming Investor Conferences

08 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire

IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update

03 ноя 2022 09:05:00 Источник Nasdaq GlobeNewswire